NCT05612906 Renal Nerve Denervation(RDN) and Renal Function
| NCT ID | NCT05612906 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Zhengrong Huang |
| Condition | Effects of RDN on Renal Function |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2022-06-01 |
| Primary Completion | 2023-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2022-06-01 with a primary completion date of 2023-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Current studies have found the efficacy of RDN in the treatment of hypertension, however, the safety of RDN in renal function is still lacking. Therefore, the investigators are aimed to study the effect of RDN on renal function.
Eligibility Criteria
Inclusion Criteria: 1.18\<age≤75 years; 2.clinic blood pressure ≥ 140/90 mmHg or 24-hour ambulatory blood pressure monitoring average blood pressure ≥ 135/85 mmHg after taking 3 or more antihypertensive drugs for more than 4 weeks; 3.essential hypertension, renal parenchymal hypertension, or hypertension patients who are willing to receive RDN ; 4.who signed informed consent and were approved by the Ethics Committee of the First Affiliated Hospital of Xiamen University. Exclusion Criteria: * pregnant women or lactating patients; * identified secondary hypertension or Pseudo hypertension; * whose renal arteries were unsuitable for ablation * obvious bleeding tendency and blood system diseases; * malignant tumors or end-stage diseases; ⑥Severe peripheral vascular disease, abdominal aortic aneurysm; ⑦A history of the acute coronary syndrome within two weeks; ⑧acute or severe systemic infection; ⑨drug or alcohol dependence or refusal to sign informed consent.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05612906 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Effects of RDN on Renal Function. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05612906 currently recruiting?
Yes, NCT05612906 is actively recruiting participants. Contact the research team at huangzhengrong@xmu.edu.cn for enrollment information.
Where is the NCT05612906 trial being conducted?
This trial is being conducted at Xiamen, China.
Who is sponsoring the NCT05612906 clinical trial?
NCT05612906 is sponsored by Zhengrong Huang. The trial plans to enroll 50 participants.